Cuba will soon have a laboratory specialized in transgenic foods at the National Institute of Hygiene, Epidemiology and Microbiology (INHEM), in the capital, informed PhD José Antonio Carrera, head of its Laboratories Department.
Molecular biology laboratory in Cuban westernmost province has processed nearly 7,000 samples to detect COVID 19
Since its inauguration last January 30, the molecular biology laboratory of Pinar del Rio has processed 6,952 real-time PCR diagnostic tests for the detection of the novel SARS-CoV-2 coronavirus.
Cuba reports 937 new cases of COVID-19, 940 discharges and 5 deaths
Cuba studied 16,274 samples for COVID-19, resulting in 937 positive ones. The country accumulates 2,177,217 samples taken and 39,941 positive.
Cuba to have its own vaccine against rabbit hemorrhagic disease
By the end of this year, experts expect that a Cuban vaccine against rabbit hemorrhagic disease, the main threat to the health of these animals, could be submitted for registration.
Cuba opens a clinic to detect sequelae of coronavirus in children
A multidisciplinary consultation to identify possible sequelae of COVID-19 in children who suffered from the disease, caused by the SARS CoV-2 coronavirus, will open in the Cuban province of Matanzas next February 22.
Cuba warns of complex epidemiological situation in the country in February
Cuba reported today 715 new positive cases of the SARS-CoV-2 virus, which the National Director of Epidemiology, Dr. Francisco Duran Garcia, said that with this figure, this month will necessarily exceed the number of diagnosed cases in January (15,536).
Cuba reports 715 new cases, 609 discharges and 3 deaths
Cuba studied 17,807 samples for COVID 19, resulting in 715 positive ones. The country accumulates 2,160,943 samples taken and 39,004 positive.
Warning! Obesity is dangerous to COVID-19 patients
Much has been said about the need to maintain healthy eating habits, due to the multiple health conditions derived from obesity: high blood pressure, diabetes and circulatory or orthopedic problems, among others.
Cuba with notable achievements in congenital heart disease detection
In Cuba, prenatal diagnosis of congenital heart disease detection is over 85 percent, a figure higher than in other countries in the world, according to national experts.
Cuba maintains its commitment against children´s cancer
Cancer is the second leading cause of death in Cuba and in the region of the Americas, and its diagnosis changes the lives of those who suffer from it, especially at an early age. Therefore, to raise awareness about the challenges faced by these children and adolescents and their families, every February 15 is commemorated as International Children's Cancer Day.
Cuba reports 823 new cases of COVID-19, 839 discharges and four deaths
Cuba studied 18,561 samples for COVID-19, resulting in 823 positive ones. The country accumulates 2,106,593 samples taken and 36,595 positive.
Cuban province keeps orthopedic equipment production despite US blockade
The workers of the Provincial Laboratory of Technical Orthopedics of Camaguey (eastern region) reverse with their daily actions the limitations of the economic, commercial and financial blockade of the United States against Cuba, with the aim of offering a better quality of life to the patients.
Age, a pre-disposing factor for torpid evolution in COVID-19 patients
Although the factors leading COVID-19 patients to a severe stage are still uncertain, hospitals have observed that age is a predisposing factor in adults over 65 years old and found that their level of mobility and comorbidities also have an impact.
Cuban President Stresses Advancement of Cuban COVID-19 Vaccines
Cuban President Stresses Advancement of Cuban COVID-19 Vaccinesavana, Feb 10 (ACN) Cuban President Miguel Diaz-Canel stressed the advancement of clinical trials of the four Cuban candidate vaccines against COVID 19.
UNIDO highlights development of Cuban anti-COVID-19 vaccines
The United Nations Industrial Development Organization (UNIDO) highlighted Cuba science’s ability to develop four anti-COVID-19 vaccine candidates, among them Soberana 02, soon to enter Phase III trials and bound to be the first Latin American vaccine against the SARS-CoV-2 virus.